ReviewDrug delivery2022

Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers.

Ruijia Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.